Simon Travis
Appearances
A SINGLE-CELL THERAPEUTIC ATLAS OF ANTI-TUMOUR NECROSIS FACTOR THERAPY IN INFLAMMATORY BOWEL DISEASE
DateMay 8, 2023BACKGROUND: Mesenteric fat is increasingly believed to exert an important influence on intestinal inflammation. A hallmark of severe Crohn's disease (CD) is the accumulation of mesenteric fat around the inflamed intestine, typically in the terminal ileum…- DateMay 9, 2023Background: Patients with inflammatory bowel disease (IBD) often modify their diet in attempt to manage their disease and symptoms. In some cases, dietary changes involve excessive restriction, which may place patients at risk for adverse consequences…
Speakers
Presenter
Icahn School of Medicine, Mount Sinai - DateMay 7, 2023BACKGROUND: Anti-granulocyte macrophage-colony stimulating factor autoantibodies (anti-GM-CSF) have been associated with development of Crohn’s disease (CD) and complications at time of diagnosis. There are limited data on anti-GM-CSF as a prognostic biomarker in CD…
Speakers
Presenter
- DateMay 20, 2024BACKGROUND: Disease clearance in ulcerative colitis (UC) is defined as concurrent achievement of clinical, endoscopic, and histologic remission…
Presenter
Western UniversitySpeakers
Icahn School of Medicine at Mount SinaiKatholieke Universiteit Leuven Universitaire Ziekenhuizen LeuvenWestern University - DateMay 18, 2024BACKGROUND: Acute upper gastrointestinal bleeding(AUGIB) is a common emergency, with 10% linked to varices1, requiring swift evaluation. METHODS: Prospective multi-center study (3 May–2 July 2022) of adults (>16) with AUGIB in 152 UK hospitals…